• Skip to main content

DistilGovHealth

DistilNFO GovHealth Advisory

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CDC Issues New Guidance for Doctors Treating Vaping-related Illnesses

Share:

October 16, 2019

The Centers for Disease Control and Prevention (CDC) released new guidance Friday for clinicians whose patients might have lung illnesses related to vaping.

Because the illness is new, there had been no guidelines for how clinicians should treat patients suspected of having the illness.

Having official guidance from the CDC becomes more important as the U.S. enters the flu season, officials said Friday.

Several symptoms of the flu and other viral infections overlap with those associated with the vaping illness.

As such, all patients with apparent respiratory infections, like the flu, should be asked about their vaping history.

“We recommend that clinicians maintain a high index of suspicion for influenza and other respiratory infections in all individuals with respiratory symptoms who also have a history of use of e-cigarette or vaping products,” said Dr. Ram Koppaka, medical officer for the National Center for Immunization and Respiratory Diseases at the CDC.

“Part of maintaining that index of suspicion is consideration that any given individual might have lung injury, they may have an infection, or they may have both.”

The CDC also says clinicians should strongly advise patients to stop using e-cigarettes or vaping products after treatment. Some clinicians have told the CDC they were concerned about patients resuming use after treatment.

The guidance also recommends clinicians follow up with patients within one or two weeks after being discharged from the hospital.

The CDC and the Food and Drug Administration don’t know what is causing the illnesses, but most patients have reported vaping THC products.

“I think that there will be multiple causes and potentially more than one root cause,” said Dr. Anne Schuchat, principal deputy director of the CDC.

“I do think the phenomenon we’re seeing is going to have an explanation. It may not be tomorrow. It may take a few months to really understand the portion of the illness that’s due to some new risky practice in the preparation of these materials or other other causes.”

The CDC on Thursday confirmed 26 deaths since the outbreak started early this summer.

In all, 1,299 confirmed or probable lung injury cases related to vaping have been reported to the CDC so far, an increase of 219 cases from figures released last week.

Date: October 16, 2019

Source: The Hill

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Major Payers Find HHS Finalized Nondiscrimination Rule Too NarrowMajor Payers Find HHS Finalized Nondiscrimination Rule Too Narrow
  • New Clinically Validated Sleepcheck App LaunchesNew Clinically Validated Sleepcheck App Launches
  • Apple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care SectorApple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care Sector
  • Google Moves Further Into Healthcare: a Timeline of the Last YearGoogle Moves Further Into Healthcare: a Timeline of the Last Year
  • Superb Healthcare At Ultra-Low Prices? How Singapore Does ItSuperb Healthcare At Ultra-Low Prices? How Singapore Does It
  • AI, Machine Learning, and Blockchain are Key for Healthcare InnovationAI, Machine Learning, and Blockchain are Key for Healthcare Innovation

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications